MBD3 has been demonstrated to promote the metastasis and growth of various digestive tract tumors, and, in liver cancer, it can enhance the growth, angiogenesis, and metastasis of tumor cells by inhibiting the tissue factor pathway inhibitor 2 (TFPI2) [9]. Here, TFPI2 is linked to liver cancer.